Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing
Cystic fibrosis is caused by mutations in the CFTR chloride channel. Here, the authors develop a gene therapy approach using the programmable nuclease AsCas12a to correct a splicing mutation in CFTR, and show efficient repair of the mutation and recovery of CFTR function in patient-derived organoids...
Guardado en:
Autores principales: | Giulia Maule, Antonio Casini, Claudia Montagna, Anabela S. Ramalho, Kris De Boeck, Zeger Debyser, Marianne S. Carlon, Gianluca Petris, Anna Cereseto |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d7c2cba4da6b42e3a01044d6646c73ee |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Hit and go CAS9 delivered through a lentiviral based self-limiting circuit
por: Gianluca Petris, et al.
Publicado: (2017) -
AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines
por: Liyang Zhang, et al.
Publicado: (2021) -
Author Correction: AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines
por: Liyang Zhang, et al.
Publicado: (2021) -
A Comparative Analysis of Pricing and Reimbursement of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Europe
por: Khadidja Abdallah, et al.
Publicado: (2021) -
Repeated measures ASCA+ for analysis of longitudinal intervention studies with multivariate outcome data.
por: Torfinn S Madssen, et al.
Publicado: (2021)